331 results on '"Ateeq, Bushra"'
Search Results
2. Red-emitting polyaniline-based nanoparticle probe for pH-sensitive fluorescence imaging
3. Targeting AGTR1/NF-κB/CXCR4 axis by miR-155 attenuates oncogenesis in glioblastoma
4. An Evaluation of Monetary Policy in India: A SVAR Approach
5. Chickpea peel waste as sustainable precursor for synthesis of fluorescent carbon nanotubes for bioimaging application
6. Transcriptional network involving ERG and AR orchestrates Distal-less homeobox-1 mediated prostate cancer progression
7. Molecular Underpinnings Governing Genetic Complexity of ETS-Fusion-Negative Prostate Cancer
8. FIGURE 5 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
9. FIGURE 2 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
10. Supplementary Figure S4 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
11. Supplementary Table S3 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
12. FIGURE 1 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
13. FIGURE 3 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
14. FIGURE 4 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
15. Supplementary Methods from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
16. Data from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
17. FIGURE 7 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
18. FIGURE 6 from Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer
19. Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer.
20. Cancer Genomics and Precision Medicine: A Way Toward Early Diagnosis and Effective Cancer Treatment
21. An integrative proteomics approach identifies tyrosine kinase KIT as a novel therapeutic target for SPINK1-positive prostate cancer.
22. Transcriptional regulation of Dyskerin via canonical WNT signaling modulates sphingolipid biosynthesis and drives colorectal cancer.
23. Targeting NF-kappa B Signaling by Artesunate Restores Sensitivity of Castrate-Resistant Prostate Cancer Cells to Antiandrogens
24. Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancer
25. Abstract 4128: AJ17 potentiates agonist CD40 antibody efficacy and attenuates agonist CD40 induced PD-L1 expression and associated toxicity in murine tumor models
26. Data from AKT Inhibition Modulates H3K4 Demethylase Levels in PTEN-Null Prostate Cancer
27. Data from Identification of Targetable FGFR Gene Fusions in Diverse Cancers
28. Data from Characterization of KRAS Rearrangements in Metastatic Prostate Cancer
29. Supplementary Methods and Data (posted 7/5/2011) from Characterization of KRAS Rearrangements in Metastatic Prostate Cancer
30. Supplementary Figures from Identification of Targetable FGFR Gene Fusions in Diverse Cancers
31. Supplementary Tables from Identification of Targetable FGFR Gene Fusions in Diverse Cancers
32. Figure S1 from AKT Inhibition Modulates H3K4 Demethylase Levels in PTEN-Null Prostate Cancer
33. Supplementary Methods, Figures, Tables, and References from Characterization of KRAS Rearrangements in Metastatic Prostate Cancer
34. Molecular Discriminators of Racial Disparities in Prostate Cancer
35. Transcription networks rewire gene repertoire to coordinate cellular reprograming in prostate cancer
36. Human ERG oncoprotein represses a Drosophila LIM domain binding protein–coding gene Chip
37. Epigenetic reprogramming during prostate cancer progression: A perspective from development
38. Abstract 5585: Inhibition of CSF1R enhances the antitumor efficacy of DC derived exosomes by modulating immunosuppressive tumor microenvironment
39. Abstract 1542: MALAT1 ablation dismantles homologous recombination repair machinery and sensitizes castrate resistant prostate cancer cells to PARP inhibitor
40. Abstract 6246: WNT signaling-mediated DKC1 expression drives stemness associated with colorectal cancer
41. Human ERG Oncoprotein Represses Chip/LDB1 LIM-Domain Binding Gene in Drosophila
42. Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer.
43. Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate Cancer
44. The Role of Sarcosine Metabolism in Prostate Cancer Progression
45. Corrigendum to “Pharmacological inhibition of DNA methylation induces proinvasive and prometastatic genes in vitro and in vivo” [Neoplasia 10/3 (2008) 266-278]
46. Untargeted Metabolomics Showed Accumulation of One-Carbon Metabolites to Facilitate DNA Methylation during Extracellular Matrix Detachment of Cancer Cells
47. AGTR1 Overexpression Defines a Subset of Breast Cancer and Confers Sensitivity to Losartan, an AGTR1 Antagonist
48. Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
49. Coordinated Regulation of Polycomb Group Complexes through microRNAs in Cancer
50. Mechanistic Rationale for Inhibition of Poly(ADP-Ribose) Polymerase in ETS Gene Fusion-Positive Prostate Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.